Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 07-2010 | 07-2009 | 07-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,596 | N/A | -2,709 | -3,480 | -5,967 |
| Depreciation Amortization | 20 | N/A | 55 | 61 | 72 |
| Accounts receivable | -8 | N/A | -2,219 | -80 | 620 |
| Other Working Capital | 2,310 | N/A | -1,097 | -305 | 93 |
| Other Operating Activity | 82 | 0 | 2,307 | 311 | 188 |
| Operating Cash Flow | $-1,191 | $N/A | $-3,662 | $-3,492 | $-4,994 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 823 |
| PPE Investments | 29 | N/A | -39 | -2 | -30 |
| Other Investing Activity | -2 | 0 | 104 | 0 | 0 |
| Investing Cash Flow | $27 | $N/A | $65 | $-2 | $793 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 200 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 536 | N/A | 3,942 | 2,014 | N/A |
| Other Financing Activity | -100 | 0 | -189 | -6 | -133 |
| Financing Cash Flow | $636 | $N/A | $3,752 | $2,008 | $-133 |
| Beginning Cash Position | 557 | N/A | 752 | 2,237 | 6,572 |
| End Cash Position | 29 | N/A | 908 | 752 | 2,237 |
| Net Cash Flow | $-529 | $N/A | $155 | $-1,485 | $-4,335 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,191 | N/A | -3,662 | -3,492 | -4,994 |
| Capital Expenditure | -15 | N/A | -39 | -2 | -30 |
| Free Cash Flow | -1,206 | 0 | -3,701 | -3,493 | -5,025 |